Occludin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Occludin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Occludin is a transmembrane tight junction protein that plays a critical role in maintaining [blood-brain barrier](/entities/blood-brain-barrier) function. It regulates paracellular permeability and protects the CNS from peripheral molecules [1].
Structure
Occludin is a 522 amino acid protein with:
Four transmembrane domains creating two extracellular loops
N-terminal cytoplasmic domain: Interacts with the actin cytoskeleton
C-terminal cytoplasmic tail: Binds to ZO-1 and other scaffolding proteins
Paracellular Transport: Regulates the passage of molecules
Signaling: Participates in barrier assembly and remodeling
Signaling Functions
Interacts with ZO-1 scaffolding protein
Responds to inflammatory cytokines
Regulates barrier remodeling during development
Role in Neurodegeneration
Alzheimer's Disease
Occludin expression is reduced in AD brains
BBB breakdown correlates with neuropathology
[Amyloid-beta](/proteins/amyloid-beta) can disrupt occludin-based barriers [2]
Parkinson's Disease
Contributes to neuroinflammation
May affect drug delivery to the brain
Stroke
Acute disruption of occludin after stroke
Target for neuroprotective therapies
Marker of BBB damage
Multiple Sclerosis
Downregulated in MS lesions
Loss correlates with disease activity
Therapeutic Implications
Drug Delivery
Understanding occludin regulation can improve BBB targeting
Cytokine modulation can transiently open barriers
Biomarkers
CSF occludin levels indicate BBB damage
Useful for monitoring disease progression
Key Publications
[Cummins, Occludin in barrier function (2012)](https://doi.org/10.1016/j.tcb.2012.01.002). Trends in Cell Biology.
[Hawkins & Davis, The blood-brain barrier in neurodegeneration (2005)](https://doi.org/10.1016/j.pharmthera.2005.01.004). Pharmacology & Therapeutics.
[Sweeney et al., Blood-brain barrier breakdown in Alzheimer's disease (2019)](https://doi.org/10.1038/s41582-019-0167-3). Nature Reviews Neurology.
Background
The study of Occludin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Cummins PM, "Occludin in barrier function." Trends in Cell Biology (2012)](https://doi.org/10.1016/j.tcb.2012.01.002)
[Hawkins BT, Davis TP, "The blood-brain barrier/neurovascular unit in health and disease." Pharmacology & Therapeutics (2005)](https://doi.org/10.1016/j.pharmthera.2005.01.004)
[Sweeney MD, Sagare AP, Zlokovic BV, "Blood-brain barrier breakdown in Alzheimer's disease and other neurodegenerative disorders." Nature Reviews Neurology (2019)](https://doi.org/10.1038/s41582-019-0167-3)